Nuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst
Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
finanzen23h
Japanese Market Sharply Higher
The Japanese market is trading sharply higher on Thursday, extending the gains in the previous three sessions, following the mixed ...
precisionmedicineonline4h
More Precise Response Markers Needed for Enhertu Amid HER2 Biomarker Disruption, Researchers Say
By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.
Orthopedics This Week4h
When Surgery Isn’t an Option, This Knee Tumor May Still Be Treated
Your patient presents with pain, swelling and impaired knee function. One rare diagnosis is non-malignant tenosynovial giant ...
healthcareasiamagazine20h
Burjeel Cancer Institute launches new centre in Al Ain
Burjeel Cancer Institute has opened a new centre at Burjeel Hospital Al Ain.